14 ML atezolizumab 60 MG/ML Injection [Tecentriq]20 ML atezolizumab 60 MG/ML Injection [Tecentriq]
NO BLACK BOX WARNING
Dosage & administration
Administer TECENTRIQ intravenously over 60 minutes. If the first infusion is tolerated, all subsequent infusions may be delivered over 30 minutes.
Urothelial Carcinoma
NSCLC
* In the adjuvant setting, administer TECENTRIQ following resection and up to 4 cycles of platinum-based chemotherapy as 840 mg every 2 weeks, 1200 mg every 3 weeks or 1680 mg every 4 weeks for up to 1 year. * In the metastatic setting, administer TECENTRIQ as 840 mg every 2 weeks, 1200 mg every 3 weeks, or 1680 mg every 4 weeks. * When administering with chemotherapy with or without bevacizumab, administer TECENTRIQ prior to chemotherapy and bevacizumab when given on the same day.
Small Cell Lung Cancer
* Administer TECENTRIQ as 840 mg every 2 weeks, 1200 mg every 3 weeks, or 1680 mg every 4 weeks. When administering with carboplatin and etoposide, administer TECENTRIQ prior to chemotherapy when given on the same day.
Hepatocellular Carcinoma
* Administer TECENTRIQ as 840 mg every 2 weeks, 1200 mg every 3 weeks, or 1680 mg every 4 weeks. Administer TECENTRIQ prior to bevacizumab when given on the same day. Bevacizumab is administered at 15 mg/kg every 3 weeks.
Melanoma
* Following completion of a 28 day cycle of cobimetinib and vemurafenib, administer TECENTRIQ 840 mg every 2 weeks, 1200 mg every 3 weeks, or 1680 mg every 4 weeks with cobimetinib 60 mg orally once daily (21 days on /7 days off) and vemurafenib 720 mg orally twice daily.
Your request will be referred to the appropriate Genentech, Inc. medical professional, such as a Tecentriq pharmaceutical rep; Medical Science Liaison (MSL) or medical affairs.
Need to report a Tecentriq issue?
ONLINE FORMReport adverse event
Learn More
You can report a Tecentriq adverse event on MedWatch, the FDA's medical product safety reporting program for health professionals, patients and consumers.
prior authorization
Tecentriq Prior authorization resources
Complete Letter of Medical Necessity
NOT PROVIDED BY BRANDCoverage Authorization Request
Coverage Authorization Appeals
Learn More
If available, these templates are provided by the brand to help you navigate insurance, especially with newer drugs.
Benefits investigation
Combined Prescriber Service Form and Patient Consent Form
Patient Consent Form - English
Patient Consent Form - Spanish
Prescriber Service Form - Online Portal
Learn More
Benefits investigations are conducted to determine whether a therapy is covered under a patient's insurance, if a prior authorization is required, and which specialty pharmacies are preferred.
Reimbursement help (FRM)
NOT PROVIDED BY BRANDReimbursement help (FRM) resources
Learn More
Some brands offer a field reimbursement manager who will work with your clinical staff and preferred pharmacy to help make sure patients don't fall through the cracks.
financial assistance
Tecentriq Financial assistance options
Co-pay savings program
commercial only
Combined Prescriber Service Form and Patient Consent Form
Patient Consent Form - English
Patient Consent Form - Spanish
Prescriber Service Form - Online Portal
Enroll in Patient Savings Program
Learn More
Overview
Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)
Patient benefit
A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max
Patient eligibility
Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance
How to sign up
Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form
Bridge program
commercial only
Learn More
Overview
Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)
Patient benefit
100% free (outside of insurance)
Patient eligibility
HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries
How to sign up
Typically HCP assisted enrollment (via form)
Foundation programs
under insured
no insurance
goverment insurance
65+
Combined Prescriber Service Form and Patient Consent Form
Patient Consent Form - English
Patient Consent Form - Spanish
Prescriber Service Form - Online Portal
Genentech Patient Foundation Application Form - Prescriber Form
Learn More
Overview
Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned
Patient benefit
Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted
Patient eligibility
Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.
How to sign up
Patients submit proof of out-of-pocket drug costs to charities for reimbursement
patient education
Tecentriq Patient education
Getting started on Tecentriq
NOT PROVIDED BY BRANDInstructions For Use: Adjuvant NSCLC
Patient toolkit
Side Effect Tracker for Patients - Melanoma
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
About Tecentriq: Adjuvant NSCLC
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
3-Step Treatment Plan with Tecentriq: Adjuvant NSCLC
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Side Effects: Adjuvant NSCLC
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Receiving Tecentriq: Adjuvant NSCLC
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Preparing for Infusion
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Your Care Team (NSCLC & SCLC)
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Questions to Ask Your Doctor: Adjuvant NSCLC
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Patient Resources: Adjuvant NSCLC
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Tips for Caregivers: Adjuvant NSCLC
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Sign Up For Tecentriq Starter Folder (NSCLC & SCLC)
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Tecentriq 3-Step Treatment Plan Brochure: Adjuvant NSCLC
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
How Tecentriq May Help Brochure: Adjuvant NSCLC
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link